Osteoporosis drugs on every 2026 South Carolina Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in South Carolina cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
11 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Wellcare Value Script$4.80/moS4802-144 | Wellcare Classic$9.70/moS4802-070 | Humana Basic Rx Plan$10.10/moS5884-134 | Humana Value Rx Plan$65.60/moS5884-188 | HealthSpring Extra Rx$71.20/moS5617-359 | SilverScript Choice$98.40/moS5601-018 | AARP Medicare Rx Saver from UHC$122.10/moS5921-354 | AARP Medicare Rx Preferred from UHC$139.20/moS5921-391 | BlueCross Rx Value$139.70/moS5953-001 | Humana Premier Rx Plan$145.60/moS5884-155 | HealthSpring Assurance Rx$152.50/moS5617-218 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 2$2.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00 | Tier 2$7.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 6$5.00 | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d |
| risedronategeneric Actonel | Tier 2$3.00QL 1/30d | Not covered | Not covered | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Not covered | Not covered | Not covered |
| ibandronategeneric Boniva | Tier 2$3.00QL 1/30d | Tier 325%QL 1/30d | Tier 325%QL 1/28d | Tier 319%QL 1/28d | Tier 317%QL 1/28d | Tier 433%QL 1/30d | Tier 318%QL 1/28d | Tier 317%QL 1/28d | Tier 6$5.00QL 1/28d | Tier 3$45.00QL 1/28d | Tier 321%QL 1/28d |
| Proliadenosumab | Not covered | Not covered | Tier 430%QL 1/180d | Tier 434%QL 1/180d | Tier 430%QL 1/180d | Not covered | Not covered | Not covered | Not covered | Tier 450%QL 1/180d | Tier 431%QL 1/180d |
| denosumab biosimilarsJubbonti, Ospomyv and others | Tier 440%QL 1/180d | Tier 427%QL 1/180d | Not covered | Not covered | Not covered | Tier 433%QL 1/180d | Tier 436%QL 1/180d | Tier 435%QL 1/180d | Tier 450%QL 2/365d | Not covered | Not covered |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Not covered | Not covered | Tier 5PA25%QL 2.24/28d | Tier 5PA26%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Tier 5PA33%QL 2.24/28d | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Tier 5PA25%QL 2.48/28d | Tier 5PA31%QL 2.48/28d | Tier 5PA25% | Not covered | Tier 5PA25%QL 2.48/28d |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Not covered | Tier 5PA31%QL 1.56/30d | Tier 5PA25% | Not covered | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.